Petar Mamula, M.D.
Petar Mamula, M.D.
Associate Professor of Pediatrics at the Children's Hospital of Philadelphia
Department: Pediatrics
Contact information
The Children's Hospital of Philadelphia
Division of Gastroenterology & Nutrition
34th & Civic Center Blvd.
Philadelphia, PA 19104
Division of Gastroenterology & Nutrition
34th & Civic Center Blvd.
Philadelphia, PA 19104
Office: 2155909146
Email:
mamula@email.chop.edu
mamula@email.chop.edu
Education:
MD
University of Zagreb School of Medicine, Croatia, 1991.
Permanent linkMD
University of Zagreb School of Medicine, Croatia, 1991.
Selected Publications
Stephens M, Shepanski M, Mamula P, Markowitz J, Brown K, Baldassano R: Safety and steroid sparing experiences in infliximab for Crohn's disease at a Pediatric inflammatory bowel disease center. Am J Gastroenterol 98: 104-111, 2003.Mamula P, Markowitz JE, Brown KA, Hurd LB, Piccoli DA, Baldassano RN: Infliximab as a novel therapy for pediatric ulcerative colitis. J Pediatr Gastroenterol Nutr 34: 307-311, 2002.
Mamula P, Piccoli DA, Peck SN, Markowitz JE, Baldassano RN: Total dose intravenous infusion of iron-dextran for iron-deficiency anemia in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 34: 286-290, 2002.
Mamula P, Telega G, Markowitz J, Brown K, Russo P, Piccoli D, Baldassano R: Inflammatory bowel disease (BD) in children 5 years of age and younger: a diagnostic dilemma. Am J Gastroenterol 97: 2005-2010, 2002.
Kamath BM, Mamula P, Baldassano RN, Markowitz JE: Listeria meningitis after treatment with infliximab. J Pediatr Gastroenterol Nutr 34: 410-413, 2002.
Batres A, Mamula P, Baldassano R: Resolution of severe peristomal pyoderma gangrenosum with infliximab in a child with Crohn's disease. J Pediatr Gastroenterol Nutr 34, 2002.
Mamula P, Mascarenhas MR, Baldassano RN: Biological and novel therapies for IBD. Pediatr Clin North Am 49(1): 1-25, 2002.
Mamula P: Crohn's disease. The Five Minute Pediatric Consult. Schwartz, M.W. (eds.). Williams & Wilkins, Inc. Baltimore. Page: 288-89, 2002.